πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 37 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10071095

1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurologica

Addex Pharma, S.A. Β· Granted Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9938270

Mono-phosphate salt of 6-fluoro-2-[4-(pyridin-2-yl)but-3-yn-1-yl]imidazo[1,2A]pyridine (di

Addex Pharma, S.A. Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9765091

Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modulators of m

Addex Pharma, S.A. Β· Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9737533

1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention

Addex Pharma, S.A. Β· Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9266834

1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modul

Addex Pharma, S.A. Β· Granted Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9226930

1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention

Addex Pharma, S.A. Β· Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9132122

1β€²,3β€²-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1β€²H-[1,4β€²]bipyridinyl-2β€²-ones

Addex Pharma, S.A. Β· Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9114138

1β€²,3β€²-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1β€²H-[1,4β€²] bipyridinyl-2β€²-ones

Addex Pharma, S.A. Β· Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9085577

7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modu

Addex Pharma, S.A. Β· Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9073907

Thiazoles derivatives and their use as positive allosteric modulators of metabotropic glut

Addex Pharma, S.A. Β· Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9067891

1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modula

Addex Pharma, S.A. Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8946205

1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators

Addex Pharma, S.A. Β· Granted Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8937060

1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention

Addex Pharma, S.A. Β· Granted Tue Jan 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8906939

3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives

Addex Pharma, S.A. Β· Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8883826

Alkynyl derivatives as modulators of metabotropic glutamate receptors

Addex Pharma, S.A. Β· Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8841323

1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modul

Addex Pharma, S.A. Β· Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8785486

Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGlu

Addex Pharma, S.A. Β· Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8779129

Triazinedione derivatives as GABAB receptor modulators

Addex Pharma, S.A. Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8748621

1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones

Addex Pharma, S.A. Β· Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8722894

1,3-disubstituted-4-phenyl-1H-pyridin-2-ones

Addex Pharma, S.A. Β· Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8716480

7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modu

Addex Pharma, S.A. Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8697744

Substituted 5,6-dihydro-4H-thiazolo[4,5-E]indazoles and their use as positive allosteric m

Addex Pharma, S.A. Β· Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8697689

Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors

Addex Pharma, S.A. Β· Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8691813

Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors

Addex Pharma, S.A. Β· Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted